327 related articles for article (PubMed ID: 15382115)
21. Strategies to inhibit cyst formation in ADPKD.
Calvet JP
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1205-11. PubMed ID: 18434615
[TBL] [Abstract][Full Text] [Related]
22. Histopathological analysis of renal cystic epithelia in the Pkd2WS25/- mouse model of ADPKD.
Thomson RB; Mentone S; Kim R; Earle K; Delpire E; Somlo S; Aronson PS
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F870-80. PubMed ID: 12851251
[TBL] [Abstract][Full Text] [Related]
23. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis in autosomal-dominant polycystic kidney disease.
Bello-Reuss E; Holubec K; Rajaraman S
Kidney Int; 2001 Jul; 60(1):37-45. PubMed ID: 11422734
[TBL] [Abstract][Full Text] [Related]
25. Blockade of interleukin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease.
Lee EJ; Song SA; Mun HW; Yoo KH; Choi SY; Park EY; Park JH
Nephrology (Carlton); 2014 Aug; 19(8):471-8. PubMed ID: 24724588
[TBL] [Abstract][Full Text] [Related]
26. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD.
Du J; Wilson PD
Am J Physiol; 1995 Aug; 269(2 Pt 1):C487-95. PubMed ID: 7653531
[TBL] [Abstract][Full Text] [Related]
27. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver.
Ubara Y
Ther Apher Dial; 2006 Aug; 10(4):333-41. PubMed ID: 16911186
[TBL] [Abstract][Full Text] [Related]
28. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules.
Isse K; Harada K; Nakanuma Y
Liver Int; 2007 Jun; 27(5):672-80. PubMed ID: 17498253
[TBL] [Abstract][Full Text] [Related]
29. The exocyst localizes to the primary cilium in MDCK cells.
Rogers KK; Wilson PD; Snyder RW; Zhang X; Guo W; Burrow CR; Lipschutz JH
Biochem Biophys Res Commun; 2004 Jun; 319(1):138-43. PubMed ID: 15158452
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease.
Blazer-Yost BL; Blacklock BJ; Flaig S; Bacallao RL; Gattone VH
Cell Physiol Biochem; 2011; 28(6):1255-64. PubMed ID: 22179013
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
32. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
33. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
34. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.
Ye M; Grantham JJ
N Engl J Med; 1993 Jul; 329(5):310-3. PubMed ID: 8321258
[TBL] [Abstract][Full Text] [Related]
35. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.
Wallace DP; Quante MT; Reif GA; Nivens E; Ahmed F; Hempson SJ; Blanco G; Yamaguchi T
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1463-71. PubMed ID: 18753297
[TBL] [Abstract][Full Text] [Related]
36. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro.
Ye M; Grant M; Sharma M; Elzinga L; Swan S; Torres VE; Grantham JJ
J Am Soc Nephrol; 1992 Oct; 3(4):984-94. PubMed ID: 1333294
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1beta regulates vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 secretion by human oviductal epithelial cells and stromal fibroblasts.
Nasu K; Itoh H; Yuge A; Kawano Y; Yoshimatsu J; Narahara H
Gynecol Endocrinol; 2006 Sep; 22(9):495-500. PubMed ID: 17071533
[TBL] [Abstract][Full Text] [Related]
38. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
[TBL] [Abstract][Full Text] [Related]
39. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling.
Di Girolamo N; Wakefield D; Coroneo MT
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2430-7. PubMed ID: 16723453
[TBL] [Abstract][Full Text] [Related]
40. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
